STOCK TITAN

C3is Inc. Announces Closing of $2 Million Registered Direct Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

C3is (NASDAQ: CISS) closed a registered direct offering on October 9, 2025 selling 800,000 shares of common stock at $2.50 per share for aggregate gross proceeds of $2.0 million. The company expects to use net proceeds and existing cash for general corporate purposes and working capital. Aegis Capital acted as exclusive placement agent. The offering was made under an effective Form F-3 shelf registration (No. 333-285135) declared effective on March 6, 2025, and a final prospectus supplement was filed with the SEC.

C3is (NASDAQ: CISS) ha chiuso un'offerta diretta registrata il 9 ottobre 2025 vendendo 800.000 azioni ordinarie a $2,50 per azione per un importo lordo aggregato di $2,0 milioni. La società prevede di utilizzare i proventi netti e liquidità esistente per scopi generali aziendali e capitale circolante. Aegis Capital ha agito come agente di collocamento esclusivo. L'offerta è stata effettuata nel quadro di un registro di durata Form F-3 efficace (n. 333-285135) dichiarato efficace il 6 marzo 2025, e un supplemento al prospetto finale è stato depositato presso la SEC.

C3is (NASDAQ: CISS) cerró una oferta directa registrada el 9 de octubre de 2025 vendiendo 800,000 acciones de acciones ordinarias a $2.50 por acción para ingresos brutos agregados de $2.0 millones. La compañía espera utilizar los ingresos netos y el efectivo existente para propósitos generales de la empresa y capital de trabajo. Aegis Capital actuó como agente de colocación exclusivo. La oferta se realizó bajo un registro de estante Form F-3 vigente (No. 333-285135) declarado efectivo el 6 de marzo de 2025, y se presentó un suplemento final de prospecto ante la SEC.

C3is (NASDAQ: CISS)2025년 10월 9일에 등록된 직접 공모를 마감하고 80만 주의 보통주를 주당 $2.50에 매각하여 총매출액 $2.0백만의 총수익을 얻었습니다. 회사는 순수익 및 기존 현금을 일반 기업 목적 및 운전자본으로 사용할 것으로 예상합니다. Aegis Capital은 독점 배정 대리인으로 활동했습니다. 이 공모는 2025년 3월 6일에 유효하게 선언된 Form F-3 선반 등록(No. 333-285135) 하에 이루어졌으며, 최종 투자설명서 보충서가 SEC에 제출되었습니다.

C3is (NASDAQ: CISS) a conclu une offre directe enregistrée le 9 octobre 2025 en vendant 800 000 actions ordinaires à $2,50 par action, pour un produit brut total de $2,0 millions. La société prévoit d'utiliser le produit net et les liquidités existantes pour des finalités générales d'entreprise et du fonds de roulement. Aegis Capital a agi en tant qu'agent de placement exclusif. L'offre a été réalisée dans le cadre d'un enregistrement de gabarit Form F-3 efficace (No. 333-285135) déclaré efficace le 6 mars 2025, et un supplément de prospectus final a été déposé auprès de la SEC.

C3is (NASDAQ: CISS) schloss ein registriertes Direktangebot am 9. Oktober 2025 ab und veräußerte 800.000 Aktien Stammaktien zu $2,50 pro Aktie für Bruttoerlöse in Höhe von $2,0 Millionen. Das Unternehmen plant, Erlöse aus dem Nettoverkauf und vorhandenen Barmitteln für allgemeine Unternehmenszwecke und Betriebskapital zu verwenden. Aegis Capital fungierte als exklusiver Platzierungsagent. Das Angebot wurde unter einer wirksamen Form F-3 Shelf-Registrierung (Nr. 333-285135) durchgeführt, die am 6. März 2025 wirksam erklärt wurde, und ein endgültiger Prospektanhang wurde bei der SEC eingereicht.

C3is (NASDAQ: CISS) أتمت عرضاً مباشراً مسجّلاً في 9 أكتوبر 2025 ببيع 800,000 سهم من الأسهم العادية بسعر $2.50 للسهم، بإجمالي عوائد إجمالية قدرها $2.0 مليون. تتوقع الشركة استخدام العائدات الصافية والنقد المتاح لديها لـأغراض عامة للشركة ورأس المال العامل. قامت Aegis Capital بدور الوكيل الحصري للتوزيع. كان العرض بموجب سجل رف Shelf Form F-3 فعال (الرقم 333-285135) المعتمد الذي أصبح فعالاً في 6 مارس 2025, وتم تقديم ملاحق نشرة الإصدار النهائية إلى هيئة الأوراق المالية والبورصات.

C3is (NASDAQ: CISS) 已于 2025年10月9日 完成一项注册直接发行,出售800,000股普通股,价格为每股 $2.50,总毛额募集资金为 $2.0百万。公司预计将净收益及现有现金用于一般企业用途和运营资金。Aegis Capital 担任独家配售代理人。该发行在有效的 Form F-3 货架登记(编号 333-285135)下进行,该登记于 2025年3月6日 生效,并向 SEC 提交了最终的招股说明书补充文件。

Positive
  • Raised $2.0 million in gross proceeds
  • Proceeds earmarked for working capital and corporate needs
Negative
  • Issued 800,000 new shares, creating shareholder dilution risk
  • Public offering priced at $2.50 may reflect valuation pressure

Insights

C3is completed a registered direct offering raising $2.0 million by selling 800,000 shares on October 9, 2025.

The transaction supplies immediate liquidity to C3is Inc. via sale of 800,000 common shares at $2.50 each for aggregate gross proceeds of approximately $2.0 million. The company states it will apply net proceeds and existing cash to general corporate purposes and working capital, which directly increases available short‑term funding for operations.

The primary dependency is how management allocates the proceeds; dilution from new shares is explicit and could affect existing ownership percentages. Legal and placement details are complete: the offering relied on an effective Form F-3 shelf and closed on October 9, 2025, with Aegis Capital Corp. as placement agent.

Watch for quarterly cash burn, any disclosure of specific uses of proceeds, and share count changes in the next periodic filings over the coming 90–180 days. These items will clarify whether the capital meaningfully extends liquidity or only covers short‑term needs.

ATHENS, Greece, Oct. 09, 2025 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ: CISS) (the “Company”), a ship-owning company providing dry bulk and tanker seaborne transportation services, today announced the closing of its previously announced registered direct offering with institutional investors for the purchase and sale of 800,000 shares of its Common Stock at a public offering price of $2.50, for an aggregate offering price of $2.0 million.

Aggregate gross proceeds to the Company were approximately $2.0 million. The transaction closed on October 9, 2025. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.

Aegis Capital Corp. acted as exclusive placement agent for the offering. Goodwin Procter LLP acted as U.S. counsel to the Company. Kaufman & Canoles, P.C. acted as U.S. counsel to Aegis Capital Corp.

The registered direct offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333-285135) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on March 6, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering was filed with the SEC and is available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

Interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.

About C3is Inc.

C3is Inc. is a ship-owning company providing dry bulk and crude oil seaborne transportation services. The Company owns four vessels, three handysize drybulk carriers with a total capacity of 97,664 deadweight tons (dwt) and an Aframax oil tanker with a cargo carrying capacity of approximately 115,800 dwt, resulting with a fleet total capacity of 213,464 dwt. C3is Inc.’s shares of Common Stock are listed on the Nasdaq Capital Market and trade under the symbol “CISS.”

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements those related to the intended use of the proceeds, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Company Contact:

Nina Pyndiah
Chief Financial Officer
C3is INC.
00-30-210-6250-001
E-mail: info@c3is.pro


FAQ

What did C3is (CISS) announce on October 9, 2025?

C3is closed a registered direct offering of 800,000 shares at $2.50 for total gross proceeds of $2.0 million.

How will C3is (CISS) use the $2.0 million raised on October 9, 2025?

The company expects to use net proceeds together with existing cash for general corporate purposes and working capital.

Who acted as placement agent for C3is's October 2025 offering?

Aegis Capital acted as exclusive placement agent for the offering.

Under what registration was C3is's October 9, 2025 offering made?

The offering was made under an effective Form F-3 shelf registration (No. 333-285135) declared effective on March 6, 2025.

Where can investors find the final prospectus for C3is (CISS) offering?

The final prospectus supplement and prospectus are filed with the SEC and available at www.sec.gov.
C3is

NASDAQ:CISS

CISS Rankings

CISS Latest News

CISS Latest SEC Filings

CISS Stock Data

3.91M
784.40k
22.93%
5.09%
10.56%
Marine Shipping
Industrials
Link
Greece
Athens